Pharming Group N.V. (PHAR) Free cash flow 2019–2025
Pharming Group N.V. (PHAR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$54.0MFY2025 · since FY2019: $71.5M → $54.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.0M | +2187.4% |
| FY2024 | -$2.6M | +86.2% |
| FY2023 | -$18.7M | -188.9% |
| FY2022 | $21.1M | -22.2% |
| FY2021 | $27.1M | -65.7% |
| FY2020 | $79.0M | +10.4% |
| FY2019 | $71.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice